Ajinomoto BioPharma Services is a CDMO providing APIs and intermediates for oligonucleic acids, peptides, small molecule proteins, partial antibodies, antibodies and ADCs.
As an integrated CDMO with sites in Belgium, US, Japan and India, we provide research reagent manufacturing, process development, GMP manufacturing and aseptic fill formulation services.

■Oligonucleic acids, Peptides
・Production of small-quantity, multi-product (2'-F, 2'-MOE, LNA, sgRNA, etc.) using our originally developed solid-phase synthesizer
・Innovative liquid phase synthesis for production of kg or more : AJIPHASE®
・for research, in vivo tests and diagnostic reagents
・GMP manufacturing
・Process development
・Development and validation of analytical methods

■Small molecule proteins, Partial antibodies
・Secretion production of peptides/proteins by gram-positive bacterium : CORYNEX®
・Especially highly suitable for VHH, antibody mimetics and long peptides
・Highly Efficient Non-Canonical Amino-Acids Introduction Technology
・from strain development to fermentation/purification process development and analytical assay development

■Antibodies
・Full-length Antibody Secretion production by Microbe : TARAMAX®
・Low Risk of Side Effects Caused by Glycans
・Short lead-time and low-cost
・from strain development to fermentation/purification process development and analytical assay development

■ADCs
・ext Generation Site-Specific Conjugation and Linker Technologies for ADCs : AJICAP®
・Precisely controlled DAR2 or higher DAR on specific sites
・Stable & hydrophilic linker compatible with various payloads